A simplified disease activity index for rheumatoid arthritis for use in clinical practice by Smolen, J. S., Breedveld, F. C., Schiff, M. H., Kalden, J. R., Emery, P., Eberl, G., van Riel, P. L., Tugwell, P.

Get full text

Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide by Emery, P, Breedveld, F C, Dougados, M, Kalden, J R, Schiff, M H, Smolen, J S

Get full text

Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis by Schiff, Michael H

Get full text

Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis by Schiff, M H, Burmester, G R, Kent, J D, Pangan, A L, Kupper, H, Fitzpatrick, S B, Donovan, C

Get full text

Safety of extended treatment with anakinra in patients with rheumatoid arthritis by Fleischmann, R M, Tesser, J, Schiff, M H, Schechtman, J, Burmester, G-R, Bennett, R, Modafferi, D, Zhou, L, Bell, D, Appleton, B

Get full text

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007 by Furst, D E, Breedveld, F C, Kalden, J R, Smolen, J S, Burmester, G R, Sieper, J, Emery, P, Keystone, E C, Schiff, M H, Mease, P, van Riel, P L C M, Fleischmann, R, Weisman, M H, Weinblatt, M E

Get full text

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006 by Furst, D E, Breedveld, F C, Kalden, J R, Smolen, J S, Burmester, G R, Emery, P, Keystone, E C, Schiff, M H, van Riel, P L C M, Weinblatt, M E, Weisman, M H

Get full text

Longterm safety and efficacy of etanercept in patients with rheumatoid arthritis by MORELAND, Larry W, COHEN, Stanley B, SCHIFF, Michael H, BAUMGARTNER, Scott W, TINDALL, Elizabeth A, BULPITT, Ken, MARTIN, Richard, WEINBLATT, Michael, TABORN, James, WEAVER, Arthur, BURGE, Daniel J

Get full text

Leflunomide versus methotrexate: A comparison of the European and American experience by Schiff, M. H.

Get full text

Integrated safety in tocilizumab clinical trials by Schiff, Michael H, Kremer, Joel M, Jahreis, Angelika, Vernon, Emma, Isaacs, John D, van Vollenhoven, Ronald F

Get full text

Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis by Schiff, Michael H., Whelton, Andrew

Get full text

Microemulsion formulation of cyclosporin (Sandimmun Neoral®) vs Sandimmun®: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis by Yocum, D. E., Allard, S., Cohen, S. B., Emery, P., Flipo, R. M., Goobar, J., Jayawardena, S., Job‐Deslandre, C., Jubb, R. W., Krüger, K., Lopes Vaz, A., Manger, B., Mur, E., Nygaard, H., Weiner, S. M., Rainer, F., Sack, M. R., Schiff, M. H., Schnitzer, T. J., Trigg, L. B., Whatmough, I., Schmidt, A.‐G.

Get full text

Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of... by FURST, Daniel E, SCHIFF, Michael H, FLEISCHMANN, Roy M, STRAND, Vibeke, BIRBARA, Charles A, COMPAGNONE, Daniele, FISCHKOFF, Steven A, CHARTASH, Elliot K

Get full text

Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience by MORELAND, Larry W, WEINBLATT, Michael E, KEYSTONE, Edward C, KREMER, Joel M, MARTIN, Richard W, SCHIFF, Michael H, WHITMORE, James B, WHITE, Barbara W

Get full text

Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort by Müller, Rüdiger B., MD, Kempis, Johannes von, MD, Haile, Sarah R, Schiff, Michael H., MD

Get full text

Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis by Moreland, L W, Cohen, S B, Baumgartner, S W, Tindall, E A, Bulpitt, K, Martin, R, Weinblatt, M, Taborn, J, Weaver, A, Burge, D J, Schiff, M H

Get full text

The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis by HANSEN, Karen E, HILDEBRAND, Julie P, GENOVESE, Mark C, CUSH, John J, PATEL, Supen, COOLEY, David A, COHEN, Stanley B, GANGNON, Ronald E, SCHIFF, Michael H

Get full text

Oral Abstracts 7: RA Clinical O37. Long-Term Outcomes of Early RA Patients Initiated with Adalimumab Plus Methotrexate Compared with Methotrexate Alone Following a Targeted Treatme... by Fleischmann, R., van Vollenhoven, R. F., Smolen, J., Rathmann, S., Keystone, E. C., Beattie, S., Macias, W., Dikranian, A. H., Alten, R., Klearman, M., Green, J., Gabay, C., Weinblatt, M. E., Schiff, M. H., van der Heijde, D., Hunt, L., Bissell, L.-A., Conaghan, P., McGonagle, D., Wright, H. L., Moots, R., Edwards, S. W., Hamann, P., McHugh, N., Lindsay, M. A., Haroon, M., Giles, J. T., FitzGerald, O., Cohen, C. J., Keidel, S., Plant, D., Bowes, J., Wilson, A. G., Isaacs, J., Barton, A., Williams, F. M., Spector, T., Cao, D., Memari, Y., Hyde, C. L., Ziemek, D., Shi, Y., Harrow, I., Malarstig, A., McEwen, R., Jin, X., McMahon, S. B., Soranzo, N., John, S., Wang, J., Spector, T. D., Baker, J., Litherland, G. J., Rowan, A. D., Kite, K. A., Bayley, R., Yang, P., Smith, J. P., Harper, L., Kitas, G. D., Buckley, C., Fitzpatrick, M. A., Filer, A., Raza, K., Nash, G., Muthana, M., Davies, H., Khetan, S., Adeleke, G., Hawtree, S., Ciani, B., Wilson, G., Quirke, A.-M., Wegner, N., Charles, P., Hamilton, B., Chowdhury, M., Potempa, J., Fisher, B., Thiele, G., Mikuls, T., Venables, P., Wollenhaupt, J., Stevens, R., Sieper, J., Dougados, M., Van den Bosch, F., Goupille, P., Rathmann, S. S., Maksymowych, W. P., Elewaut, D., Ramasamy, P., Murphy, C., Fitzgerald, O., Jani, M., Moore, S., Mirjafari, H., Chinoy, H., McLoughlin, Y., Preeti, S.

Get full text

Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability by BAUMGARTNER, Scott W, FLEISCHMANN, Roy M, MORELAND, Larry W, SCHIFF, Michael H, MARKENSON, Joseph, WHITMORE, James B

Get full text

Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study by JOHNSEN, Alyssa K, SCHIFF, Michael H, MEASE, Philip J, MORELAND, Larry W, MAIER, Agnes L, COBLYN, Jonathan S, HELFGOTT, Simon M, LEFF, Jonathan A, WEINBLATT, Michael E

Get full text